Cefotiam hexetil hydrochloride

盐酸头孢替安酯

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCefotiam hexetil hydrochloride
Drug Alias NameCefotiam cilexetil hydrochlorideTaketiamPansporin TTexodilSCE-2174 +[6] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsBurn infectionsPyodermaLymphadenitis +[32] 
Global Approved IndicationsBurn infectionsCystitisPyelonephritis +[20] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1990/01/01
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceutical Co LtdBeijing Boshi Antai Technology Development Co Ltd
Inactive CompaniesCangzhou Senary Chemical S&T Co LtdShandong Chuangxin Pharmacy R&D Co Ltd
Active IndicationsBurn infectionsCystitisPyelonephritis +[21] 
Inactive IndicationsPyodermaLymphadenitisMastitis +[11] 

Other Information

ATC CodeJ01DC07
Related LinksWikipediaDrugBankKEGG